Outcome of Immune Checkpoint Inhibitor and Molecular Target Agent Combination for Advanced Hepatocellular Carcinoma: Beyond Sorafenib Era

Outcome of Immune Checkpoint Inhibitor and Molecular Target Agent Combination for Advanced Hepatocellular Carcinoma: Beyond Sorafenib Era

Bibliographic Details
Main Author: Nae-Yun Heo
Format: Article
Language:English
Published: Jin Publishing & Printing Co. 2021-03-01
Series:The Korean Journal of Gastroenterology
Online Access:http://www.kjg.or.kr/journal/view.html?uid=5686&vmd=Full
id doaj-08accf1a90984c8cabd5cfcd3bd56fb9
record_format Article
spelling doaj-08accf1a90984c8cabd5cfcd3bd56fb92021-05-04T06:04:22ZengJin Publishing & Printing Co.The Korean Journal of Gastroenterology1598-99922233-68692021-03-0177314514710.4166/kjg.2021.013Outcome of Immune Checkpoint Inhibitor and Molecular Target Agent Combination for Advanced Hepatocellular Carcinoma: Beyond Sorafenib EraNae-Yun Heo0https://orcid.org/0000-0001-6571-8935Division of Gastroenterology, Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Koreahttp://www.kjg.or.kr/journal/view.html?uid=5686&vmd=Full
collection DOAJ
language English
format Article
sources DOAJ
author Nae-Yun Heo
spellingShingle Nae-Yun Heo
Outcome of Immune Checkpoint Inhibitor and Molecular Target Agent Combination for Advanced Hepatocellular Carcinoma: Beyond Sorafenib Era
The Korean Journal of Gastroenterology
author_facet Nae-Yun Heo
author_sort Nae-Yun Heo
title Outcome of Immune Checkpoint Inhibitor and Molecular Target Agent Combination for Advanced Hepatocellular Carcinoma: Beyond Sorafenib Era
title_short Outcome of Immune Checkpoint Inhibitor and Molecular Target Agent Combination for Advanced Hepatocellular Carcinoma: Beyond Sorafenib Era
title_full Outcome of Immune Checkpoint Inhibitor and Molecular Target Agent Combination for Advanced Hepatocellular Carcinoma: Beyond Sorafenib Era
title_fullStr Outcome of Immune Checkpoint Inhibitor and Molecular Target Agent Combination for Advanced Hepatocellular Carcinoma: Beyond Sorafenib Era
title_full_unstemmed Outcome of Immune Checkpoint Inhibitor and Molecular Target Agent Combination for Advanced Hepatocellular Carcinoma: Beyond Sorafenib Era
title_sort outcome of immune checkpoint inhibitor and molecular target agent combination for advanced hepatocellular carcinoma: beyond sorafenib era
publisher Jin Publishing & Printing Co.
series The Korean Journal of Gastroenterology
issn 1598-9992
2233-6869
publishDate 2021-03-01
url http://www.kjg.or.kr/journal/view.html?uid=5686&vmd=Full
work_keys_str_mv AT naeyunheo outcomeofimmunecheckpointinhibitorandmoleculartargetagentcombinationforadvancedhepatocellularcarcinomabeyondsorafenibera
_version_ 1721481787962556416

Similar Items